Wait times for breast cancer care

por Saint-Jacques, N, Younis, T, Dewar, R, Rayson, D
Publicado 2007

Canadian supportive care recommendations for the management of anemia in patients with cancer

por Mikhael, J., Melosky, B., Cripps, C., Rayson, D., Kouroukis, C.T.
Publicado 2007

The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada

por Drucker, A., Skedgel, C., Virik, K., Rayson, D., Sellon, M., Younis, T.
Publicado 2008

Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations

por Melosky, B., Burkes, R., Rayson, D., Alcindor, T., Shear, N., Lacouture, M.
Publicado 2009

Inter-institutional pathology consultations for breast cancer: impact on clinical oncology therapy recommendations

por Price, J.A., Grunfeld, E., Barnes, P.J., Rheaume, D.E., Rayson, D.
Publicado 2010

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients

por Amir, E, Freedman, OC, Chia, S, Petrella, T, Dent, S, Tonkin, K, Ahmad, I, Rayson, D, Dranitsaris, G, Clemons, M
Publicado 2009

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer

por Dent, S., Verma, Sh., Latreille, J., Rayson, D., Clemons, M., Mackey, J., Verma, Su., Lemieux, J., Provencher, L., Chia, S., Wang, B., Pritchard, K.
Publicado 2009

The role of scientific evidence in decisions to adopt complex innovations in cancer care settings: a multiple case study in Nova Scotia, Canada

por Urquhart, R., Kendell, C., Geldenhuys, L., Ross, A., Rajaraman, M., Folkes, A., Madden, L. L., Sullivan, V., Rayson, D., Porter, G. A.
Publicado 2019

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers

por Lemieux, J., Clemons, M., Provencher, L., Dent, S., Latreille, J., Mackey, J., Pritchard, K.I., Rayson, D., Verma, Sh., Verma, Su., Wang, B., Chia, S.
Publicado 2009

Guidelines for the diagnosis and management of carcinoid tumours. Part 1: The gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group

por Maroun, J., Kocha, W., Kvols, L., Bjarnason, G., Chen, E., Germond, C., Hanna, S., Poitras, P., Rayson, D., Reid, R., Rivera, J., Roy, A., Shah, A., Sideris, L., Siu, L., Wong, R.
Publicado 2006